Regulatory & Policy

10:55 AM - 11:20 AM

Use Case: Application of AI to Predict a New Class of Novel Synthetic Lethal Targets Leading to More Effective and Safer Oncology Therapeutic Programs

  • AI research and insights using the ExpansiveAI platform
  • Scalable mining of data connections, testing masses of hypotheses, cognitive computing and ML to discover novel targets
  • Bioinformatic filtering, in-silico validation, prioritizing targets aimed at vulnerable cancer cells harboring a specific gene change
  • Launching new effective and safer therapeutic programs
Spyro Mousses, Ph.D, Chief Executive Officer, Systems Oncology
/* */